GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDEXX Laboratories Inc (WBO:IDXX) » Definitions » Current Deferred Revenue

IDEXX Laboratories (WBO:IDXX) Current Deferred Revenue : €34 Mil (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is IDEXX Laboratories Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

IDEXX Laboratories's current deferred revenue for the quarter that ended in Dec. 2023 was €34 Mil.

IDEXX Laboratories Current Deferred Revenue Historical Data

The historical data trend for IDEXX Laboratories's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDEXX Laboratories Current Deferred Revenue Chart

IDEXX Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.32 34.99 35.43 35.81 34.11

IDEXX Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.81 35.34 34.87 34.93 34.11

IDEXX Laboratories Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of IDEXX Laboratories's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

IDEXX Laboratories (WBO:IDXX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDEXX Laboratories Inc (WBO:IDXX) » Definitions » Current Deferred Revenue
Comparable Companies
IQV A MTD ICLR ILMN WAT LH DGX CRL RVTY TSE:2309 TMO DHR XSWX:LONN SHSE:603259 XPAR:BIM EXAS MEDP XPAR:ERF NTRA
Traded in Other Exchanges
IDXX:USA IDXX:Mexico IX1:Germany I1DX34:Brazil
Address
One IDEXX Drive, Westbrook, ME, USA, 04092
Website
https://www.idexx.com
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 40% of its revenue from outside the United States.